Janus Kinase
Full Form of JAK
What is JAK?
Janus Kinase (JAK) is a family of intracellular tyrosine kinases that play a critical role in signal transduction from cytokine and growth factor receptors. In India, JAK inhibitors (e.g., tofacitinib, baricitinib) are increasingly used in the treatment of autoimmune and inflammatory conditions such as rheumatoid arthritis, psoriasis, and ulcerative colitis. The term JAK is widely encountered in medical literature, pharmacology, and clinical practice, particularly in rheumatology and dermatology departments. These enzymes activate the JAK-STAT signaling pathway, which regulates gene expression for immune responses. With the rising prevalence of autoimmune diseases in India, JAK inhibitors offer an oral alternative to traditional biologics, improving patient compliance. In medical entrance exams like NEET PG and AIIMS, questions on JAK-STAT pathway and its inhibitors are common, testing knowledge of molecular medicine and targeted therapy. Understanding JAK function is essential for doctors managing chronic inflammatory disorders, as it helps in selecting appropriate treatments and anticipating side effects like infections. The development of JAK inhibitors represents a significant advancement in precision medicine, with ongoing research exploring their use in COVID-19 and other viral infections. Overall, JAK is a cornerstone concept in modern immunology and therapeutics.
JAK का फुल फॉर्म
जानस काइनेज
Example
The rheumatologist prescribed a JAK inhibitor for her severe rheumatoid arthritis after conventional DMARDs failed.